BE658748A - - Google Patents

Info

Publication number
BE658748A
BE658748A BE658748DA BE658748A BE 658748 A BE658748 A BE 658748A BE 658748D A BE658748D A BE 658748DA BE 658748 A BE658748 A BE 658748A
Authority
BE
Belgium
Prior art keywords
emi
acid
phenyl
amino
amide
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE658748A publication Critical patent/BE658748A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE658748D 1964-01-27 1965-01-25 BE658748A (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH93064 1964-01-27

Publications (1)

Publication Number Publication Date
BE658748A true BE658748A (enEXAMPLES) 1965-07-26

Family

ID=4198470

Family Applications (1)

Application Number Title Priority Date Filing Date
BE658748D BE658748A (enEXAMPLES) 1964-01-27 1965-01-25

Country Status (5)

Country Link
BE (1) BE658748A (enEXAMPLES)
DE (1) DE1493824A1 (enEXAMPLES)
ES (1) ES308571A1 (enEXAMPLES)
FR (1) FR1421130A (enEXAMPLES)
NL (1) NL6414901A (enEXAMPLES)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3459538A1 (en) * 2017-09-20 2019-03-27 Sandoz AG Crystalline salts of a dextroamphetamine prodrug

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
WO2003072046A2 (en) * 2002-02-22 2003-09-04 New River Pharmaceuticals Inc. Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
PT1644019E (pt) * 2003-05-29 2012-05-23 Shire Llc Compostos de anfetamina resistentes ao abuso
JP4691500B2 (ja) 2003-09-30 2011-06-01 シャイア エルエルシー 過剰摂取又は乱用を防止するための薬学組成物
JP2010512413A (ja) 2006-12-11 2010-04-22 ケムファーム・インコーポレーテッド アンフェタミンの非標準アミノ酸結合体およびそれらの製造方法および使用方法
WO2011133348A1 (en) 2010-04-21 2011-10-27 Pharmacofore, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
US8779191B2 (en) * 2010-12-20 2014-07-15 Cambrex Charles City, Inc. Methods and compositions for preparing lisdexamfetamine and salts thereof
WO2023055830A1 (en) 2021-09-29 2023-04-06 Ensysce Biosciences, Inc. Enzyme-cleavable methadone prodrugs and methods of use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3459538A1 (en) * 2017-09-20 2019-03-27 Sandoz AG Crystalline salts of a dextroamphetamine prodrug
WO2019057765A1 (en) * 2017-09-20 2019-03-28 Sandoz Ag CRYSTALLINE SALTS OF A PRODUCT OF DEXTROAMPHETAMINE

Also Published As

Publication number Publication date
ES308571A1 (es) 1966-06-01
FR1421130A (fr) 1965-12-10
DE1493824A1 (de) 1969-05-22
NL6414901A (enEXAMPLES) 1965-07-28

Similar Documents

Publication Publication Date Title
BE658748A (enEXAMPLES)
Turk et al. . alpha.-Methyl amino acids. Resolution and amino protection
CH624932A5 (enEXAMPLES)
CH657359A5 (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutique les contenant.
Ressler et al. The Synthesis of the Tetrapeptide Amide S-Benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide
EP0462884A1 (fr) Dérivés de TRH, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA1193247A (fr) Procede de preparation de nouveaux derives du 3-amino- pregn-5ene et de leurs sels
FR2460291A1 (fr) Nouveaux tripeptides agissant sur le systeme nerveux central et leur procede de preparation
CH639369A5 (fr) Benzamides heterocycliques substitues et leurs procedes de preparation.
CA1265804A (fr) Derives de la 1-benzene sulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
CA1251000A (fr) Dipeptides, leur preparation et les medicaments qui les contiennent
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
CH617923A5 (enEXAMPLES)
FR2605004A1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
RU2017748C1 (ru) Производные нитратоалкановых кислот или их фармацевтически приемлемые соли
BE893553A (fr) Derives de la proline et procede pour les preparer
CA1037038A (fr) Procede d'obtention de nouvelles urees tricycliques
US4921941A (en) Orally active antiandrogens
EP0169755B1 (fr) Nouveaux dérivés de l'acide 4-hydroxy 3-quinoléine carboxylique subsititués en 2 par une fonction aminée, leur préparation, leur application comme médicaments, les compositions les renfermant et les intermédiaires nouveaux obtenus
EP0374029B1 (fr) Application de benzamides substitués comme gastromoteurs
WO1996027593A1 (fr) Analogues de l'arginine ayant une activite en tant qu'inhibiteurs de la no synthase
FR2513994A1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2541996A1 (fr) Derives de benzamide
CH658786A5 (fr) Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.
BE832190A (fr) Derives dipeptidiques et leur production